U.S. blood donors are tested at each donation for human T‐lymphotropic virus (HTLV) antibodies. Depending on donor incidence and other mitigation/removal technologies, a strategy of one‐time selective donor testing should… Click to show full abstract
U.S. blood donors are tested at each donation for human T‐lymphotropic virus (HTLV) antibodies. Depending on donor incidence and other mitigation/removal technologies, a strategy of one‐time selective donor testing should be considered.
               
Click one of the above tabs to view related content.